Global Urinalysis Market Driven by Growing Demand for Point-of-Care Diagnostic Testing

The global urinalysis market is projected to grow at a CAGR of 6.7% from USD 1.87 billion in 2021 to USD 2.87 billion by 2030, driven by the rising incidence of kidney and urinary tract disorders, growing demand for point-of-care diagnostic testing, increase in aging population and higher healthcare expenditure. In addition, the increasing prevalence of chronic diseases such as diabetes and hypertension, which are linked to kidney and urinary tract disorders, accompanied by technological advancements in urinalysis testing equipment, such as the development of automated urinalysis systems, is expected to fuel market growth.

These are the latest findings of Emergen Research (Vancover, BC, Canada), a market research and consulting company.

The increasing prevalence of kidney diseases and urinary tract infections, particularly among elderly individuals, is a key factor driving the urinalysis market growth. This has been accompanied by the rising occurrences of chronic conditions like diabetes and hypertension, leading to higher incidences of kidney and urinary tract conditions. Additionally, there is an increase in demand for point-of-care diagnostic tests, spurring the development of sophisticated urinalysis testing devices. These devices deliver accurate results quickly, making them a great option for use in ERs, outpatient clinics and other healthcare settings. Technology has also enabled the production of automated urinalysis systems which provide fast and precise results, making them perfect for high-throughput clinical laboratories.

Nevertheless, the market growth could be hindered by the high costs of automated urinalysis systems and other diagnostic testing devices. Additionally, a lack of skilled professionals to carry out diagnostic tests, especially in developing countries, could also impede market growth. Inaccurate results obtained from some urinalysis tests which can lead to misdiagnosis and inadequate treatment can also have a negative impact on market growth. Moreover, the absence of standardization in urinalysis testing processes could affect market growth, as different methods can result in different outcomes, making it difficult to compare results from different labs.

Currently, the urinalysis market is experiencing several trends and innovations including the emergence of advanced urinalysis testing devices and the growing use of point-of-care diagnostic tests. The use of AI and machine learning for urinalysis testing is also a trend that is likely to become more popular in the future. Furthermore, with the increasing demand for easy-to-use portable urinalysis test equipment, particularly in low-income settings, manufacturers are producing innovative devices that are cost-effective and require minimal training to operate.

Geographically, North America is expected to hold the largest revenue share in the global urinalysis market during the forecast period due to the rising prevalence of chronic renal disease, hypertension and diabetes, well-established sophisticated healthcare systems, and significant healthcare expenditure in the region. The European urinalysis market is expected to register a steady revenue growth over the forecast period owing to beneficial reimbursement policies and government guidelines and regulations, as well as developed healthcare infrastructure in the region. The Asia Pacific urinalysis market is expected to register a high revenue growth over the forecast period, thanks to the rapidly developing healthcare industry and increasing investments by key market players.

Related Links:
Emergen Research

Visit expo >

Gold Member

Pharmacogenetics Panel

VeriDose Core Panel v2.0

Verification Panels for Assay Development & QC
Seroconversion Panels

New

Troponin I Test

Quidel Triage Troponin I Test

New

HIV-1 Test

HIV-1 Real Time RT-PCR Kit